SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is seeing renewed momentum driven by strong prescription data and positive sentiment surrounding the oral Wegovy rollout, which is being viewed as a strategic advantage against competitors. Investors are closely watching the upcoming earnings report, with community discussions heavily focused on the company's ability to maintain its market position through potential M&A and improved guidance.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently experiencing heightened retail activity and speculative momentum driven by its integration into the broader Japanese blockchain and IoT data economy narratives. While the community is actively debating the potential impact of ecosystem expansions like Janction, sentiment remains divided between long-term holders accumulating positions and skeptics focused on historical price underperformance.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing significant momentum and retail interest as investors connect the company's specialized MRAM technology to broader AI memory and aerospace growth narratives. Market participants are actively debating the sustainability of this rapid move, with bulls pointing to recent defense contracts and low float as catalysts for a potential squeeze, while some skeptics express concerns over high valuations and technical resistance.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as shareholders react to reports that FDA Commissioner Marty Makary may be replaced, a move widely interpreted by the community as a positive catalyst that could alleviate regulatory friction for the company's oncology pipeline. Investors are actively discussing the potential for smoother sBLA reviews and increased global expansion, fueling bullish sentiment despite recent volatility and ongoing legal disputes.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following an FDA meeting to define the pivotal Phase 3 registration path for CAD-1005 in treating heparin-induced thrombocytopenia, though community sentiment remains polarized due to concerns over high-frequency social media spamming and future dilution risks.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

Abbott Laboratories is experiencing significant downward pressure as investors weigh disappointing earnings guidance and the financial implications of its recent acquisition of Exact Sciences. The community is actively debating whether the current price levels represent a deep-value buying opportunity or a value trap amid ongoing litigation concerns and broader institutional de-risking within the healthcare sector.

Investment Managers Series Trust II - Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF (SNDQ) is seeing significant volume and trader attention as market participants attempt to hedge against the rapid, parabolic price appreciation in SanDisk (SNDK). The community is actively debating the sustainability of the semiconductor sector's momentum, with many users employing SNDQ as a tactical vehicle to bet on a potential correction or reversal.

X-Energy, Inc. operates as an energy company The firm focuses on modular nuclear reactors and fuel technology for clean energy generation. The company was founded by Kam Ghaffarian and Eben Mulder on 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-energy Inc

X-energy is trending following a successful IPO that saw significant interest due to its strategic backing by Amazon and its position as a key infrastructure player in the AI power-demand narrative. The community is actively debating the company's valuation compared to peers, with investors highlighting the company's industrial partnerships and proprietary TRISO fuel technology as major differentiators for long-term scalability.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is currently a focal point for investors debating its long-term infrastructure value versus its recent price volatility, with community sentiment split between frustration over performance and optimism surrounding its sovereign cloud capabilities and ongoing network burn. Discussions are dominated by speculation about future government partnerships and the impact of tokenomic updates, as traders monitor whether it can maintain structural support levels amidst broader market pressure.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as market participants closely monitor the iShares 20+ Year Treasury Bond ETF amid heightened geopolitical tensions in the Middle East and ongoing debates over Federal Reserve interest rate policy. Community sentiment remains split between those positioning for a long-term recession and deflationary impulse, and those wary of persistent inflation and rising Treasury yields driven by government spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Promising Small Cap Stocks To Add to Your Watchlist - April 27th

POET Technologies, X-Energy, Critical Metals, Direxion Daily MU Bull 2X Shares, Caravelle International Group, Spring Valley Acquisition, and Youxin Technology are the seven Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of publicly trade...

Representative image of two businessmen shaking hands after a deal.

YAAS On Track For Its Best Single-Day Gains In Almost 10 Months – What’s Driving The Rally?

Youxin Technology said it had reached a deal with seven YATOP shareholders to acquire their equity stake in the company.

Equity

Biotech Breakthroughs and Energy Deals Send These Stocks Soaring

A powerful wave of dealmaking, clinical breakthroughs, and infrastructure buildouts is driving renewed momentum with companies spanning energy, biotech, semiconductors, and AI ecosystems delivering headline-making developments. $USEG, $QUIK, $KBLB, $YAAS, $SGMT, $DKI, $GLND

Youxin Technology Ltd Reports Financial Results for Fiscal Year 2025

Youxin Technology Ltd Reports Financial Results for Fiscal Year 2025 Youxin Technology Ltd Reports Financial Results for Fiscal Year 2025 PR Newswire GUANGZHOU, China, Jan. 29, 2026 GUANGZHOU, China...

Youxin Technology (YAAS) stock gained investor attention on Wednesday morning after the company signed a definitive agreement to acquire a controlling stake in Celnet Technology Co., a Chinese Salesforce.com partner.Youxin is a China-based SaaS (Software as a Service) and PaaS (Platform as a Service) provider focused on digital transformation for retail businesses. The strategic move aims to expand Youxin's presence in enterprise customer relationship management (CRM) and boost its capabilities in artificial intelligence-powered solutions.<a href="https://stocktwits.com/symbol/YAAS">Youxin Technology's stock</a> traded over 68% higher in Wednesday’s premarket. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.&nbsp;Under the agreement signed on Sept. 22, 2025, Youxin will purchase a 51% equity interest in Celnet for approximately RMB 5.24 million ($736,000), with additional cash and equity-based incentives tied to future performance milestones.“Celnet’s enterprise-focused CRM expertise and its AI-enabled solutions will create immediate synergies with Youxin Technology’s retail-focused SaaS and PaaS platforms. We believe this combination strengthens our competitive moat, enhances our long-term revenue growth potential, and positions us as a leading player in China’s digital transformation ecosystem,” said Youxin CEO Shaozhang Lin.The acquisition positions Youxin to accelerate its expansion into CRM services and deliver AI-enabled automation capabilities. The company is targeting enterprise-grade solutions that go beyond simple task management, aiming instead to enable sophisticated multi-domain workflows and intelligent agent collaboration.Youxin Technology's stock has lost over 97% of its value year-to-date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/iren-stock-surged-15-percent-today-here-is-a-price-target-update/chD1drjR33t">IREN Stock Surged 15% Today – Here’s A Price Target Update</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Youxin Technology Stock Soared 68% Today – Here’s What Happened

The company is set to acquire a controlling stake in Celnet Technology Co., aiming to expand its presence in enterprise customer relationship management and boost its capabilities in artificial intelligence-powered solutions.

Youxin Technogy Ltd. operates as an investment holding company. It is a software as a service and platform as a service provider. The firm develops, uses and controls business applications without the need to purchase complex information technology infrastructure. The company was founded by Sun Jin Hou and Lin Shao Zhang on October 21, 2022 and is headquartered in Guangzhou, China.

Youxin Technology Ltd - Ordinary Shares - Class A

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Current Price	$0.96
Prev Close	$1.07
Open	$1.07
Dividend Yield	0.00%
50-Day Moving Average	$1.05
Beta	1.08
Avg. Volume	8.89M
PE Ratio	-0.19

52-Week High	$560.00
52-Week Low	$0.7503
Market Capitalization	$12.06M
EPS (Annual)	-$1.04
Price to Book	1.32
Revenue Per Employee	$24,521.54

YAAS
Youxin Technology Ltd - Ordinary Shares - Class A

Feed

News

Sentiment

Fundamentals

Info

Latest YAAS News

YAASYouxin Technology Ltd - Ordinary Shares - Class A